IRIS
CARLO STELLA, CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.706
EU - Europa 1.225
AS - Asia 239
AF - Africa 214
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 8.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.634
FI - Finlandia 379
IE - Irlanda 265
NG - Nigeria 213
DE - Germania 162
CN - Cina 153
FR - Francia 120
NL - Olanda 73
CA - Canada 72
IT - Italia 63
GB - Regno Unito 55
SE - Svezia 31
TR - Turchia 27
RU - Federazione Russa 24
IL - Israele 22
BE - Belgio 17
CL - Cile 11
IN - India 11
IR - Iran 9
A2 - ???statistics.table.value.countryCode.A2??? 7
AT - Austria 7
AR - Argentina 6
ES - Italia 6
RO - Romania 6
HK - Hong Kong 4
JP - Giappone 4
AU - Australia 3
BD - Bangladesh 3
CH - Svizzera 3
GR - Grecia 3
PL - Polonia 3
UA - Ucraina 3
IQ - Iraq 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BR - Brasile 1
CO - Colombia 1
DK - Danimarca 1
HR - Croazia 1
KR - Corea 1
NO - Norvegia 1
SA - Arabia Saudita 1
SG - Singapore 1
SI - Slovenia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 8.416
Salva come PNG Salva come JPEG
Città #
Wilmington 1.412
Chandler 1.321
San Mateo 534
Helsinki 377
Ann Arbor 354
Dublin 265
Leawood 263
Lawrence 238
Princeton 238
Benin City 213
Boardman 189
Shanghai 149
Fairfield 130
New York 120
Paris 119
Woodbridge 105
Ashburn 97
Amsterdam 72
Toronto 69
London 51
Seattle 39
San Diego 35
Falls Church 26
Kocaeli 26
Norwalk 26
Milan 19
Brussels 17
Monmouth Junction 13
Gunzenhausen 12
Phoenix 12
Redmond 12
Moscow 10
Abbiategrasso 9
Pune 8
Andover 6
Redwood City 6
Vienna 6
Clearwater 5
Des Moines 5
Falkenstein 5
Houston 5
Munro 5
Sacramento 5
Berlin 4
Cambridge 4
Hanover 4
Novokuznetsk 4
Saint Paul 4
Buffalo 3
Cardiff 3
Cologne 3
Cupertino 3
Frankfurt am Main 3
Freiburg im Breisgau 3
Henderson 3
Las Vegas 3
Montréal 3
Pozzuoli 3
Raleigh 3
Santa Clara 3
Athens 2
Azzano Decimo 2
Canegrate 2
Eden Prairie 2
Hong Kong 2
Jacksonville 2
La Canada Flintridge 2
Lappeenranta 2
Leipzig 2
Los Angeles 2
St Petersburg 2
Tappahannock 2
Voronezh 2
Adliswil 1
Apo 1
Auckland 1
Basra 1
Beijing 1
Belovo 1
Bogotá 1
Brisbane 1
Büdelsdorf 1
Canberra 1
Central District 1
Chicago 1
Collingswood 1
Dallas 1
Ferrara 1
Genoa 1
Hoffman 1
Johannesburg 1
Kemerovo 1
Ljubljana 1
Luhansk 1
Mersin 1
Málaga 1
Nanjing 1
Naples 1
New Haven 1
Newark 1
Totale 6.737
Salva come PNG Salva come JPEG
Nome #
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis 133
Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy 66
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma 62
TUMOR-HOMING CELLS ENGINEERED TO PRODUCE TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) 60
Detection of maternal progenitor cells in human umbilical cord blood by single-colony karyotyping 58
MIXTURE OF DEFIBROTIDE AND G-CSF AND ITS USE FOR ACTIVATING HAEMATOPOIETIC PROGENITORS 58
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH) 58
Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis 57
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade? 57
INVITRO MEGAKARYOCYTOPOIESIS IN PATIENTS WITH HIV-RELATED THROMBOCYTOPENIC PURPURA 56
D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies 55
Radioimmunotherapy and secondary leukemia : a case report 54
Cell therapy: achievements and perspectives 54
EFFECT OF RECOMBINANT GAMMA-INTERFERON ON THE PROLIFERATIVE ACTIVITY OF CULTURED LEUKEMIC-CELLS 54
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®) 54
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 54
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-a: evidence for a tyrosine-kinase-dependent process 53
UMBILICAL-CORD BLOOD AS A SOURCE OF HEMATOPOIETIC STEM-CELLS - FROM RESEARCH TO CLINIC 53
ACQUIRED CYCLIC THROMBOCYTOPENIATHROMBOCYTOSIS WITH PERIODIC DEFECT OF PLATELET-FUNCTION 52
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma 51
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K delta/gamma Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 50
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 50
Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory Hodgkin Lymphoma 49
Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors 49
Stem cells and stem cell transplantation 49
Anticancer cell therapy with TRAIL-armed CD34+ progenitor cells 49
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes 49
Cellule staminali emopoietiche 48
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 48
Antitumor activity of adenovirally transduced CD34+ cells expressing membrane-bound TRAIL 48
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY 48
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 48
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide 48
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia 47
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells 47
EFFECT OF RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA ON HUMAN-BONE MARROW DERIVED MEGAKARYOCYTIC PROGENITOR CELLS 46
BIOLOGICAL ASPECTS AND CLINICAL-APPLICATIONS OF LONG-TERM BONE-MARROW CULTURE - A MEETING REPORT 46
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma 46
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 46
USE OF MULTI-KINASE INHIBITORS IN THE TREATMENT OF VASCULAR HYPERPERMEABILITY 46
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA 45
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 45
AUTOLOGOUS TRANSPLANT FOR CHRONIC MYELOGENOUS LEUKEMIA USING MARROW TREATED EX-VIVO WITH MAFOSFAMIDE 45
ESTABLISHMENT OF 2 EPSTEIN-BARR VIRUS NEGATIVE BURKITT CELL-LINES FROM A PATIENT WITH AIDS AND B-CELL LYMPHOMA 44
Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells 44
Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation sf the c-jun amino-terminal kinases in stromal cells 44
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia : evidence for premature aging of the myeloid compartment 44
INVITRO AND INVIVO EFFECTS OF RECOMBINANT INTERFERON GAMMA ON THE GROWTH OF HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME 44
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome 44
CD34-POSITIVE CELLS - BIOLOGY AND CLINICAL RELEVANCE 43
Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma : Final results of a multicenter phase II study 43
Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene 43
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders 43
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma 43
OLIGODEOXYNUCLEOTIDES ANTISENSE TO C-ABL SPECIFICALLY INHIBIT ENTRY INTO S-PHASE OF CD34(+) HEMATOPOIETIC-CELLS AND THEIR DIFFERENTIATION TO GRANULOCYTE-MACROPHAGE PROGENITORS 42
Ex vivo expansion of hematopoietic cells and their clinical use 42
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling 42
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 42
Amifostine (WR-2721) selective protection against melphalan genotoxicity 42
IN VITRO GROWTH OF BONE MARROW-DERIVED MULTIPOTENT AND LINEAGE-RESTRICTED HEMATOPOIETIC PROGENITOR CELLS IN MYELODYSPLASTIC SYNDROMES 42
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice 41
High-dose sequential chemotherapy and in vivo Rituximab-purged stem cell autografting in mantle cell lymphoma : a 10-year update of the R-HDS regimen 41
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells 41
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 41
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL) 41
Chronic myeloid leukemia in first chronic phase not responding to alpha-interferon: outcome and prognostic factors after autologous transplantation 41
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors. 41
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation : results from a named patient program at four Italian centers 41
Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation 40
Ex vivo manipulation of hematopoietic stem cells for transplantation: The potential role of amifostine 40
The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide 40
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma : a single institution experience 40
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 40
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide 40
NATURAL-KILLER-CELL REGENERATION AFTER TRANSPLANTATION WITH MAFOSFAMIDE PURGED AUTOLOGOUS BONE-MARROW 40
EFFECTS OF RECOMBINANT ALPHA-INTERFERONS AND GAMMA-INTERFERONS ON THE INVITRO GROWTH OF CIRCULATING HEMATOPOIETIC PROGENITOR CELLS (CFU-GEMM, CFU-MK, BFU-E, AND CFU-GM) FROM PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIA 39
Effects of the tyrosine kinase inhibitor AG957 and an anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells 39
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma 39
Nonmyeloablative conditioning, unmanipulated haploidentical stem cell transplantation and post-infusion cyclophosphamide for advanced lymphomas 39
INTERFERONS AS BIOLOGIC MODULATORS OF HEMATOPOIETIC-CELL PROLIFERATION AND DIFFERENTIATION 39
The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase 39
EFFECTS OF RECOMBINANT HUMAN H-SUBUNIT AND L-SUBUNIT FERRITINS ON INVITRO GROWTH OF HUMAN GRANULOCYTE MONOCYTE PROGENITORS 39
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing 39
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma 39
Stem cell manipulation: why and how performing peripheral blood progenitor cell purging 39
Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood 39
In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor 38
USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH LYMPHOID MALIGNANCIES TRANSPLANTED WITH UNPURGED OR ADJUSTED-DOSE MAFOSFAMIDE-PURGED AUTOLOGOUS MARROW 38
High response rate and manageable toxicity with an intensive, short-term chemotherapy program for Burkitt’s lymphoma in adults 38
DEFECTIVE INVITRO GROWTH OF THE HEMATOPOIETIC PROGENITOR CELLS IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME 38
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunological responses in indolent B-cell lymphoma patients with relapsed and measurable disease : a pilot study 38
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34+ cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial 38
Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma : long-term follow-up 38
STEM-CELLS AND STEM-CELL FACTOR(S) 38
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation 38
Transforming growth factor beta(3) inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis 38
Biology and clinical applications of marrow mesenchymal stem cells 37
Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Agonistic Receptors for Cancer Therapy 37
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) 37
The novel PI3K-ò inhibitor TGR-1202 enhances brentuximab vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. 37
Totale 4.587
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.659
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/20212.452 5 12 7 6 8 810 378 157 479 330 9 251
2021/20221.352 82 5 24 288 19 20 32 176 136 198 301 71
2022/20233.549 516 111 307 433 338 300 2 319 629 297 247 50
2023/20241.201 143 230 359 44 35 136 76 141 26 11 0 0
Totale 8.556